A Clinical Study of FRAX Fracture Risk Assessment Tool Combined with Bone MineraDensity and Bone Metabolic Markers to Evaluate Fracture Risk in Postoperative Patients with Thyroid Cancer

WU Qian, WANG Yanan, LU Feng, JIA Yingnan, FU Ning, LU Cunzhi

PDF(989 KB)
Welcome to Labeled Immunoassays and Clinical Medicine website!
PDF(989 KB)
Labeled Immunoassays and Clinical Medicine ›› 2022, Vol. 29 ›› Issue (8) : 1359-1362. DOI: 10.11748/bjmy.issn.1006-1703.2022.08.021
Clinical Investigation

A Clinical Study of FRAX Fracture Risk Assessment Tool Combined with Bone MineraDensity and Bone Metabolic Markers to Evaluate Fracture Risk in Postoperative Patients with Thyroid Cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 29(8): 1359-1362 https://doi.org/10.11748/bjmy.issn.1006-1703.2022.08.021

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(989 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备18063657号-2
Copyright © Labeled Immunoassays and Clinical Medicine, All Rights Reserved.
Tel: 010-68515701,68517801　E-mail: bjmy@circ.com.cn

/

〈 〉